FrederickMartinGolombMD

Melanoma, Surgical Oncology (Other than Breast)

Physician

Dr. Golomb is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

NYU Grossman School of MedicineResidency, Surgery, 1950 - 1956
Johns Hopkins University School of MedicineInternship, Transitional Year, 1949 - 1950
University of Rochester School of Medicine and DentistryClass of 1949

PubMed

95 citations
“Microscopic satellites” are more highly associated with regional lymph node metastases than is primary melanoma thickness
Terence J. Harrist, Darrell S. Rigel, Calvin L. Day, Arthur J. Sober, Robert A. Lew
Cancer. 1984-05-15
124 citations
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.
Calvin L. Day, Martin C. Mihm, Robert A. Lew, Matthew Harris, Alfred W. Kopf
Annals of Surgery. 1982-01-01
62 citations
Verification of a formula for determination of preexcision surgical margins from fixed-tissue melanoma specimens.
Mark K. Silverman, Frederick M. Golomb, Alfred W. Kopf, Caron M. Grin-Jorgensen, Katrien Vossaert
Journal of the American Academy of Dermatology. 1992-08-01

Taxol/G-Csf + Standard Therapy Versus Standard Therapy For NSC Lung CancerNational Center For Research Resources1995–1996
Decarbazine VS Decarbazine And Chemotherapy For Malignant MelanomaNational Center For Research Resources1994–1995
Adjuvant Chemoradiation After Gastric Resection For AdenocarcinomaNational Center For Research Resources1994–1995
Interferon And Chemotherapy For Metastatic Head/Neck CarconomaNational Center For Research Resources1994
Interferon Alpha 2 For Resected High Risk Primary Metastatic MelanomaNational Center For Research Resources1994
Adjuvant Chemotherapy And Endocrine Therapy For Node Negative Breast CancerNational Center For Research Resources1991–1994
Tamoxifen Or CAF Treatment Of Postmenopausal Breast Cancer Patients-- Phase IIINational Center For Research Resources1993
Chemo/Chemohormonal Therapy In Premenopausal WomenNational Center For Research Resources1992–1993
Adjuvant Chemoendocrine Treatment For Postmenopausal WomenNational Center For Research Resources1992
Recombinant Gamma Interferon For Malignant MelanomasNational Center For Research Resources1991
Phase III Chemotherapy Of Advanced Soft Tissue SarcomasNational Center For Research Resources1991
Cis-Platin/Etoposide And Bleomycin/Ifosfamide In Testicular CancerNational Center For Research Resources1991